Payment overview · 2025
General Payments
$97.50
4 reported records · 2 companies
Healthcare provider profile · identity verified
Derek J Metoyer, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · OPELOUSAS, LA · NPI 1942384870
Verified facts
What the public records show
CMS Open Payments records show Derek J Metoyer, M.D. received $97.50 in general payments during 2025 across 4 reported records.
AstraZeneca Pharmaceuticals LP accounted for 71.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 168 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $69.51 | 71.3% | 3 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $27.99 | 28.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $97.50 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $69.51 | 3 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $27.99 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 168 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
168 | 26 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 1003 | 163 |
| Atorvastatin Calcium | Atorvastatin Calcium | 975 | 142 |
| Pantoprazole Sodium | Pantoprazole Sodium | 882 | 143 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 796 | 139 |
| Potassium Chloride | Potassium Chloride | 578 | 90 |
| Montelukast Sodium | Montelukast Sodium | 561 | 81 |
| Diclofenac Sodium | Diclofenac Sodium | 555 | 81 |
| Gabapentin | Gabapentin | 553 | 77 |
| Furosemide | Furosemide | 531 | 83 |
| Hydrochlorothiazide | Hydrochlorothiazide | 493 | 73 |
| Fluticasone Propionate | Fluticasone Propionate | 415 | 74 |
| Metformin Hcl | Metformin Hcl | 382 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 374 | 57 |
| Losartan Potassium | Losartan Potassium | 373 | 49 |
| Trazodone Hcl | Trazodone Hcl | 361 | 49 |
| Tizanidine Hcl | Tizanidine Hcl | 351 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 324 | 50 |
| Nifedipine Er | Nifedipine | 284 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 270 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 266 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 260 | 48 |
| Carvedilol | Carvedilol | 247 | 42 |
| Clonidine Hcl | Clonidine Hcl | 245 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 235 | 46 |
| Hydralazine Hcl | Hydralazine Hcl | 229 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 228 | 43 |
| Sucralfate | Sucralfate | 219 | 26 |
| Quetiapine Fumarate | Quetiapine Fumarate | 210 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 205 | 36 |
| Alprazolam | Alprazolam | 194 | 33 |
| Omeprazole | Omeprazole | 190 | 27 |
| Buspirone Hcl | Buspirone Hcl | 184 | 30 |
| Eliquis | Apixaban | 179 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 176 | 24 |
| Farxiga | Dapagliflozin Propanediol | 168 | 26 |
| Meloxicam | Meloxicam | 165 | 26 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 164 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 162 | 20 |
| Xarelto | Rivaroxaban | 156 | 20 |
| Pregabalin | Pregabalin | 154 | 27 |
| Valsartan | Valsartan | 153 | 26 |
| Tramadol Hcl | Tramadol Hcl | 149 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 147 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 144 | 19 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 142 | 20 |
| Levetiracetam | Levetiracetam | 132 | 17 |
| Lisinopril | Lisinopril | 132 | 26 |
| Glipizide | Glipizide | 125 | 16 |
| Alendronate Sodium | Alendronate Sodium | 122 | 17 |
| Rivastigmine | Rivastigmine Tartrate | 122 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 120 | 46 |
| Memantine Hcl | Memantine Hcl | 119 | 15 |
| Topiramate | Topiramate | 119 | 12 |
| Simvastatin | Simvastatin | 114 | 16 |
| Sertraline Hcl | Sertraline Hcl | 111 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 108 | 18 |
| Spironolactone | Spironolactone | 106 | 17 |
| Methylprednisolone | Methylprednisolone | 105 | 77 |
| Pravastatin Sodium | Pravastatin Sodium | 105 | 15 |
| Lactulose | Lactulose | 104 | 20 |
| Azithromycin | Azithromycin | 103 | 82 |
| Ramipril | Ramipril | 97 | 17 |
| Allopurinol | Allopurinol | 94 | 18 |
| Glimepiride | Glimepiride | 93 | 14 |
| Famotidine | Famotidine | 85 | 16 |
| Lubiprostone | Lubiprostone | 85 | 13 |
| Linzess | Linaclotide | 84 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 83 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 80 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 80 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 73 | 59 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 73 | 20 |
| Entresto | Sacubitril/Valsartan | 72 | suppressed |
| Mounjaro | Tirzepatide | 71 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 71 | 13 |
| Jardiance | Empagliflozin | 69 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 68 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 66 | 16 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 65 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 62 | 13 |
| Ozempic | Semaglutide | 62 | 12 |
| Olanzapine | Olanzapine | 61 | suppressed |
| Finasteride | Finasteride | 60 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 58 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 56 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 56 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 56 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 55 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 54 | suppressed |
| Latanoprost | Latanoprost | 54 | suppressed |
| Mirtazapine | Mirtazapine | 54 | suppressed |
| Ondansetron Odt | Ondansetron | 54 | 23 |
| Atenolol | Atenolol | 52 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 52 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 49 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 48 | suppressed |
| Nystatin | Nystatin | 48 | 19 |
| Risperidone | Risperidone | 47 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 46 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 46 | 25 |
| Clotrimazole | Clotrimazole | 45 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 45 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 44 | suppressed |
| Celecoxib | Celecoxib | 44 | suppressed |
| Aripiprazole | Aripiprazole | 42 | suppressed |
| Lorazepam | Lorazepam | 42 | suppressed |
| Ranolazine Er | Ranolazine | 42 | suppressed |
| Fenofibrate | Fenofibrate | 41 | suppressed |
| Januvia | Sitagliptin Phosphate | 41 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 41 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 34 |
| Baclofen | Baclofen | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Mupirocin | Mupirocin | 40 | 20 |
| Telmisartan | Telmisartan | 40 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 39 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 39 | 11 |
| Metformin Hcl Er | Metformin Hcl | 39 | suppressed |
| Carbamazepine | Carbamazepine | 38 | suppressed |
| Trulicity | Dulaglutide | 38 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 38 | suppressed |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 37 | suppressed |
| Nabumetone | Nabumetone | 37 | suppressed |
| Ibuprofen | Ibuprofen | 36 | suppressed |
| Gemfibrozil | Gemfibrozil | 35 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 35 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 35 | suppressed |
| Torsemide | Torsemide | 35 | suppressed |
| Fluconazole | Fluconazole | 34 | 20 |
| Tradjenta | Linagliptin | 34 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 34 | suppressed |
| Levofloxacin | Levofloxacin | 33 | 27 |
| Naproxen | Naproxen | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | suppressed |
| Pentoxifylline | Pentoxifylline | 32 | suppressed |
| Phenobarbital | Phenobarbital | 32 | suppressed |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 31 | suppressed |
| Ezetimibe | Ezetimibe | 31 | suppressed |
| Glipizide Er | Glipizide | 31 | suppressed |
| Ketoconazole | Ketoconazole | 31 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 30 | suppressed |
| Methotrexate | Methotrexate Sodium | 30 | suppressed |
| Methocarbamol | Methocarbamol | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 13 |
| Dexlansoprazole Dr | Dexlansoprazole | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Ibu | Ibuprofen | 26 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 25 | suppressed |
| Ingrezza | Valbenazine Tosylate | 25 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 24 | suppressed |
| Caplyta | Lumateperone Tosylate | 24 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 24 | suppressed |
| Phenytoin | Phenytoin | 24 | suppressed |
| Scopolamine | Scopolamine | 24 | suppressed |
| Budesonide | Budesonide | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 23 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Prednisone | Prednisone | 23 | 14 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 18 |
| Calcitriol | Calcitriol | 22 | suppressed |
| Haloperidol | Haloperidol | 22 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 22 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Cilostazol | Cilostazol | 21 | suppressed |
| Methimazole | Methimazole | 21 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | 12 |
| Letrozole | Letrozole | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Restasis | Cyclosporine | 19 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 18 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 18 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 17 | suppressed |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Eszopiclone | Eszopiclone | 16 | suppressed |
| Hydroxyurea | Hydroxyurea | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 11 |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 14 | suppressed |
| Cephalexin | Cephalexin | 13 | 13 |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Cetirizine Hcl | Cetirizine Hcl | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Humulin R | Insulin Regular, Human | 12 | suppressed |
| Hydrocodone-Ibuprofen | Hydrocodone/Ibuprofen | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 12 | suppressed |
| Leflunomide | Leflunomide | 12 | suppressed |
| Minoxidil | Minoxidil | 12 | suppressed |
| Novolin R | Insulin Regular, Human | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Valproic Acid | Valproic Acid | 12 | suppressed |
| Veo Insulin Syringe | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Voquezna | Vonoprazan Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $97.50 · 4 records | AstraZeneca Pharmaceuticals LP | Dexcom G6 Transmitter, FARXIGA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error